OCU410

BIOLOGICAL2 trials

Sponsors

Ocugen

Conditions

Dry Age-related Macular DegenerationGeographic Atrophy

Phase 1

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Active, not recruitingNCT06018558

OcugenGeographic Atrophy

Start: 2023-02-23End: 2030-02-03Updated: 2026-07-31

Phase 3

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

RecruitingNCT07770828

OcugenDry Age-related Macular Degeneration

Start: 2026-08-11End: 2031-07-30Target: 237Updated: 2026-08-19